Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Novartis to Spin-Off Alcon as Separate Trading Company - AOL

    www.aol.com/news/novartis-spin-off-alcon...

    Novartis announces that it will spin-off its ophthalmology division, Alcon, into a separately-traded standalone company in order to focus on its legacy pharmaceuticals business.

  3. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    On July 8, 2010, Alcon's independent director committee (IDC) had set up a $50 million litigation trust to ensure company's minority shareholders get the best deal from bidder Novartis AG. [15] On April 9, 2019, Alcon completed a 100% spin-off from Novartis. [4] [16] [17] The new standalone company is worth up to 28 billion Swiss francs. [18]

  4. Novartis' Sandoz dips on debut after lower than expected ...

    www.aol.com/news/novartis-completes-sandoz-spin...

    The debut made Sandoz the largest new entrant to the Swiss stock exchange since 2019, when another Novartis spin-off, eyecare company Alcon, was valued at about 28 billion francs.

  5. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. [127] In April 2019, Novartis completed the spin-off of Alcon as a separate commercial entity. [73] Sandoz: As of 2013, Sandoz has been recognized as the world's second-largest generic drug company.

  6. Sandoz - Wikipedia

    en.wikipedia.org/wiki/Sandoz

    Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until ...

  7. Novartis Obtains Final Shares of Alcon for $12.9 Billion - AOL

    www.aol.com/2010/12/15/novartis-obtains-final...

    Shares of Novartis (NVS) soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon (ACL) for $12.9 billion. Novartis had been trying to gain ...

  8. AbbVie - Wikipedia

    en.wikipedia.org/wiki/AbbVie

    AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. [ 2] The company's primary product is Humira (adalimumab) ($14 billion in 2023 revenues, 27 percent of total ...

  9. Alcon- Take a Look at Vision Care - AOL

    www.aol.com/news/alcon-look-vision-care...

    Founded in 1945 and based in Switzerland, Alcon AG (ALC) is a global provider of ophthalmic surgery and vision care products; previously a subsidiary of Novartis AG (NVS), Alcon became an ...